Dr. Edward Hsiao is an endocrinologist who specializes in metabolic bone diseases, such as severe osteoporosis and osteogenesis imperfecta, and other bone disorders. He also cares for patients with calcium, phosphorous, vitamin D, and parathyroid hormone disorders. He has particular interests in fibrodysplasia ossificans progressiva (a condition in which bone gradually replaces muscle and other connective tissues) and fibrous dysplasia/McCune-Albright syndrome (a disorder that causes fibrous tissue to develop in bones).
E. Hsiao's current research interests center on understanding how hormones and signaling pathways control human bone formation. His laboratory uses advanced cellular, genetic, and bioengineering tools to identify key pathways that could be targeted for disease therapies. He is also involved in clinical research to develop better diagnostic and treatment strategies for patients with bone diseases.
E. Hsiao earned his medical degree and a doctorate in molecular biology and genetics from the Johns Hopkins School of Medicine, where he also completed a residency in internal medicine. He completed fellowship training in diabetes, endocrinology and metabolism at UCSF.
E. Hsiao is a member of the Endocrine Society and American Society for Bone and Mineral Research. In addition, he actively works with patient support groups through the Fibrous Dysplasia Foundation and International Fibrodysplasia Ossificans Progressiva Association, and the International Clinical Council on FOP.
E. Hsiao serves as director of UCSF's fellowship program in diabetes, endocrinology and metabolism. He has received the March of Dimes Basil O'Connor Starter Scholar Research Award and the Doris Duke Clinical Scientist Development Award, as well as research grant funding from the National Institutes of Health.
In his free time, Hsiao enjoys reading, the outdoors and photography.